Guang-Wei Zhang1, Tian-Xiang Gu1,2, Xiao-Yu Guan1, Xue-Jun Sun3,4, Xun Qi5,6, Xue-Yuan Li7, Xiao-Bing Wang8, Feng Lv9, Lei Yu1, Da-Qing Jiang1, Rui Tang1. 1. Department of Cardiac Surgery, The First Hospital of China Medical University, Shenyang, 110001, China. 2. The Cardiovascular Research Center of China Medical University, Shenyang, 110001, China. 3. Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, 110001, China. 4. Department of Anesthesiology of the First Affiliated Hospital of Dalian Medical University, Dalian, 116000, China. 5. Department of Radiology, The First Hospital of China Medical University, Shenyang, 110001, China. 6. Key Laboratory of Diagnostic Imaging and Interventional Radiology of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China. 7. Department of Cardiology, The First Hospital of China Medical University, Shenyang, 110001, China. 8. Department of Echocardiography, The First Hospital of China Medical University, Shenyang, 110001, China. 9. Institute of Biomedical Engineering, Peking Union Medical College, Beijing, 100010, China.
Abstract
OBJECTIVES: To explore effects of hepatocyte growth factor (HGF) combined with insulin-like growth factor 1 (IGF-1) on transplanted bone marrow mesenchymal stem cells (BMSCs), for treatment of acute myocardial ischaemia. MATERIALS AND METHODS: After ligation of the left anterior descending artery, rabbits were divided into a Control group, a Factors group (HGF+IGF-1), a BMSC group and a Factors+BMSCs group. Allogenous BMSCs (1 × 10(7)) and/or control-released microspheres of 2 μg HGF+2 μg IGF-1 were intramyocardially injected into infarcted regions. Apoptosis and differentiation of implanted BMSCs, histological and morphological results, and cardiac remodelling and function were evaluated at different time points. In vitro, BMSCs were exposed to HGF, IGF-1 and both (50 ng/ml) and subsequently proliferation, migration, myocardial differentiation and apoptosis induced by hypoxia, were analysed. RESULTS: Four weeks post-operatively, the above indices were significantly improved in Factors+BMSCs group compared to the others (P < 0.01), although Factors and BMSCs group also showed better results than Control group (P < 0.05). In vitro, HGF promoted BMSC migration and differentiation into cardiomyocytes, but inhibited proliferation (P < 0.05), while IGF-1 increased proliferation and migration, and inhibited apoptosis induced by hypoxia (P < 0.05), but did not induce myocardial differentiation. Combination of HGF and IGF-1 significantly promoted BMSCs capacity for migration, differentiation and lack of apoptosis (P < 0.05). CONCLUSIONS: Combination of HGF and IGF-1 activated BMSCs complementarily, and controlled release of the two factors promoted protective potential of transplanted BMSCs to repair infarcted myocardium. This suggests a new strategy for cell therapies to overcome acute ischemic myocardial injury.
OBJECTIVES: To explore effects of hepatocyte growth factor (HGF) combined with insulin-like growth factor 1 (IGF-1) on transplanted bone marrow mesenchymal stem cells (BMSCs), for treatment of acute myocardial ischaemia. MATERIALS AND METHODS: After ligation of the left anterior descending artery, rabbits were divided into a Control group, a Factors group (HGF+IGF-1), a BMSC group and a Factors+BMSCs group. Allogenous BMSCs (1 × 10(7)) and/or control-released microspheres of 2 μg HGF+2 μg IGF-1 were intramyocardially injected into infarcted regions. Apoptosis and differentiation of implanted BMSCs, histological and morphological results, and cardiac remodelling and function were evaluated at different time points. In vitro, BMSCs were exposed to HGF, IGF-1 and both (50 ng/ml) and subsequently proliferation, migration, myocardial differentiation and apoptosis induced by hypoxia, were analysed. RESULTS: Four weeks post-operatively, the above indices were significantly improved in Factors+BMSCs group compared to the others (P < 0.01), although Factors and BMSCs group also showed better results than Control group (P < 0.05). In vitro, HGF promoted BMSC migration and differentiation into cardiomyocytes, but inhibited proliferation (P < 0.05), while IGF-1 increased proliferation and migration, and inhibited apoptosis induced by hypoxia (P < 0.05), but did not induce myocardial differentiation. Combination of HGF and IGF-1 significantly promoted BMSCs capacity for migration, differentiation and lack of apoptosis (P < 0.05). CONCLUSIONS: Combination of HGF and IGF-1 activated BMSCs complementarily, and controlled release of the two factors promoted protective potential of transplanted BMSCs to repair infarcted myocardium. This suggests a new strategy for cell therapies to overcome acute ischemic myocardial injury.
Authors: Monia Savi; Leonardo Bocchi; Emanuela Fiumana; Jean-Pierre Karam; Caterina Frati; Francesca Bonafé; Stefano Cavalli; Paolo G Morselli; Carlo Guarnieri; Claudio M Caldarera; Claudio Muscari; Claudia N Montero-Menei; Donatella Stilli; Federico Quaini; Ezio Musso Journal: J Biomed Mater Res A Date: 2015-03-11 Impact factor: 4.396
Authors: Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher Journal: N Engl J Med Date: 2006-09-21 Impact factor: 91.245
Authors: Xiaofei Guo; Yan Bai; Li Zhang; Bo Zhang; Naufal Zagidullin; Katherine Carvalho; Zhimin Du; Benzhi Cai Journal: Stem Cell Res Ther Date: 2018-02-26 Impact factor: 6.832